Episode 91: Could Moderna’s mRNA breakthrough transform cancer treatment?

Podcast: Bridge Talks Business with Milford · Milford

Opublikowano: 2026-08-31

A record share price surge put Moderna back in the headlines, but the bigger story may be what it signals for the future of medicine. Milford Investment Analyst Dr Deborah Lambie joins Ryan Bridge to discuss the breakthrough personalised cancer treatment developed by Moderna and Merck, how mRNA technology is moving beyond Covid-19 vaccines, and why investors believe this could be one of the most significant healthcare developments in years. They also explore the opportunities, risks and commercial realities behind the excitement. This podcast is intended to provide general information only. It does not take i...